Progressive multifocal leukoencephalopathy in refractory polymyositis treated with rituximab

European Journal of Internal Medicine

Volumn 22, Issue 3, 2011, Pages

  Marie, I ^a   Guegan Massardier, E ^a   Levesque, H ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

Infections; Opportunistic infections; Polymyositis; Progressive multifocal leukoencephalopathy; Rituximab

Indexed keywords

AZATHIOPRINE; CREATINE KINASE; CYCLOSPORIN; IMMUNOGLOBULIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB; VIRUS DNA;

ASPIRATION PNEUMONIA; CEREBROSPINAL FLUID ANALYSIS; DRUG TREATMENT FAILURE; HEMIANOPIA; HEMISPHERE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; JC VIRUS; LETTER; LUNG FUNCTION TEST; MUSCLE STRENGTH; MUSCLE WEAKNESS; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL CORTEX; PARIETAL CORTEX; PHYSICAL EXAMINATION; POLYMYOSITIS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; VISUAL ACUITY; VITAL CAPACITY;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIRHEUMATIC AGENTS; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MIDDLE AGED; POLYMYOSITIS;

EID: 79956020534     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2011.01.001     Document Type: Letter

References (9)

1. Marie I, Hachulla E, Hatron PY, Hellot MF, Levesque H, Devulder B, et al. Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis. J Rheumatol 2001;28:2230-7. (Pubitemid 32947868)
2. Marie I, Menard JF, Hatron PY, Hachulla E, Mouthon L, Tiev K, et al. Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis. A series of 73 patients. Arthritis Care Res 2010;62:1748-55 (Hoboken).
3. Marie I, Menard JF, Hachulla E, Benveniste O, Tiev K, et al. Infectious complications in polymyositis and dermatomyositis: A Series of 279 Patients. Semin Arthritis Rheum Nov 1 2010 Epub ahead of print.
4. Sem M, Molberg O, Lund MB, Gran JT. Rituximab treatment of the anti-synthetase syndrome: a retrospective case series. Rheumatology (Oxford) 2009;48:968-71.
5. Tan CS, Koralnik IJ. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol 2010;9:425-37.
6. Carson KR, Focosi D, Major EO, Petrini M, Richey EA, West DP, et al. Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a review from the Research on Adverse Drug Events and Reports (RADAR) project. Lancet Oncol 2009;10:816-24.
7. Molloy ES, Calabrese LH. Progressive multifocal leukoencephalopathy. A national estimate of frequency in systemic lupus erythematosus and other rheumatic disease. Arthritis Rheum 2009;60:3761-5.
8. Amend KL, Turnbull B, Foskett N, Napalkov P, Kurth T, Seeger J. Incidence of progressive multifocal leukoencephalopathy in patients without HIV. Neurology 2010;75:1326-32.
9. Carson KR, Evens AM, Richey EA, Habermann TM, Focosi D, Seymour JF, et al. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood 2009;113:4834-40.